Biotechnology Acquisition Report, 2010

Biotechnology M&A transaction data, year-end figures and contact info

The all-new Biotechnology Acquisition Report, First Edition, 2010, presents you with vital details on all publicly announced biotechnology mergers and acquisitions, not just the big deals covered by major media.  Everything you need to know about the current biotechnology merger and acquisition market is at your fingertips in this new annual report, based on the latest one-year data.

View Abstract

The Biotechnology Acquisition Report, First Edition, 2010 includes essential transaction information on biotechnology mergers and acquisitions, such as deal prices, deal terms, financial performance of acquisition targets; critical valuation figures like price/revenue and price/EBITDA multiples; plus contact information for key individuals.  Graphs and charts on market activity, rankings of largest deals and most active acquirers, as well as therapeutic areas addressed by targets in biotechnology mergers and acquisitions announced during 2009, plus a brief five-year market overview, are also included.

Order Current Edition

Get all this market intelligence and more!
●	Deal-by-deal transaction data for every biotechnology deal announced in 2009
●	Annual biotechnology M&A market activity and trend analysis
●	All the hard-to-find statistics you need to size up the market today--and tomorrow--including:     ►Price/revenue ratios     ►Price/EBITDA ratios     ►Development stage and therapeutic focus of biotech targets
●	Regular Subscription $595 (PDF) Corporate Subscription $1785 (includes Excel download and unlimited distribution within                                                             your company)